Ardent Health, Inc.

ARDT Healthcare Medical Care Facilities

Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024. In the quarter to June 2026, revenue fell 1.40%, EPS fell 76.9%, free cash flow grew 121.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

11.95 0.25 −2.05%
Market cap
$1.7B
P/E
21.7×
Fwd P/E
7.7×
Dividend yield
—
F-score
6/9
Altman Z
1.97
Beneish M
−2.77
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.19
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — 2 — — — —
Sell — — — — — — — — — — — —
Insider Ownership 84.48%

Capital & Financial Ratios $m

Market Cap 1,720.00
Revenue 6,405.94
Net Income 168.65
Free Cash Flow 304.76
Net Debt 377.31
Current Ratio 2.10 (at or above 1.5: strong)
Debt/Equity 0.63
P/E ratio 21.73
Fwd P/E 7.69
P/S ratio 0.26
P/B ratio 0.97
Past 5Y EPS Growth —
This Y EPS Growth (0.53%) (below 0%: weak)
Next Y EPS Growth 21.97% (at or above 15%: strong)
Next Y revenue growth 2.19%
Next 5Y EPS Growth 9.86%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2026 Powerpack
2025 Powerpack
2024 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 438 557 710 724
Receivables 775 743 686 696
Inventory 105 115 119 116
Other 222 304 432 371
1,618 1,833 2,059 2,055
2023 2024 2025 Q'26
Payables 475 401 458 430
ST’ Debt 19 9 23 29
Other — — — —
994 945 1,047 976

Compound Annual Growth %

10y 5y 3y
Sales — — 7.23%
Cash Flow — — 0.00%
Earnings — — (10.42%)
Book Value — — 17.50%

Revenue $m

Mar Jun Sep Dec Year
’26 1,602 1,622 — — —
’25 1,497 1,645 1,577 1,605 6,324
’24 1,439 1,471 1,450 1,606 5,966
’23 — 1,369 1,378 — 5,409
’22 — — — — 5,130
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (60) 197 — — —
’25 (25) 117 154 223 471
’24 (15) 120 90 120 315
’23 — 66 89 67 222
’22 — — — (38) (38)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (88) 158 — — —
’25 (48) 71 96 139 259
’24 (39) 82 46 38 128
’23 — 11 64 10 84
’22 — — — (189) (189)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.28 0.12 — — —
’25 0.29 0.52 (0.17) 0.32 0.96
’24 0.36 0.34 0.19 0.81 1.58
’23 — 0.44 0.31 — 1.02
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — — — 14.58 8.28

Analyst estimates 2026–2028

Powerpack
High — — — — — — — — 20.72 17.29
People
People Employees — — — — — — — 24,200 24,900 25,200
Revenue/emp, $m — — — — — 0.00 0.00 0.22 0.24 0.25
Income, $m
Income, $m Revenue — — — — — 4,870 5,130 5,409 5,966 6,324
Gross margin, % — — — — — 100.00 100.00 100.00 100.00 100.00
EBT — — — — — 296 311 152 363 286
EBT margin, % — — — — — 6.08 6.07 2.80 6.09 4.53
Net income — — — — — 245 265 129 300 230
Depreciation — — — — — 144 144 146 152 160
Per share, $
Per share, $ Revenue — — — — — 0.00 40.67 42.89 45.05 44.93
Earnings — — — — — — 2.10 1.02 1.59 0.96
Cash flow — — — — — 0.00 (0.30) 1.76 2.38 3.34
Capex — — — — — 0.00 (1.20) (1.09) (1.42) (1.51)
Free cash flow — — — — — 0.00 (1.50) 0.67 0.96 1.84
Book value — — — — — 0.00 8.24 8.52 11.49 11.98
Shares, m — — — — — — 126 126 132 141
Valuation, ×
Valuation, × P/E — — — — — 11.06 11.06 11.06 9.97 9.10
P/S — — — — — 0.36 0.36 0.36 0.38 0.20
P/B — — — — — 1.75 1.75 1.75 1.49 0.74
EV/Sales — — — — — 0.49 0.49 0.49 0.47 0.26
EV/FCF — — — — — 23.86 23.86 23.86 21.96 6.31
Cash, $m
Cash, $m Operating cash flow — — — — — 147 (38) 222 315 471
Capex — — — — — (135) (151) (137) (188) (212)
Free cash flow — — — — — 11 (189) 84 128 259
Balance, $m
Balance, $m Working capital — — — — — — 601 624 887 1,012
Total debt — — — — — — 1,178 1,187 1,095 1,099
Net debt — — — — — — 722 749 538 390
Shareholders’ equity — — — — — — 1,040 1,075 1,521 1,686
Returns, %
Returns, % ROA — — — — — 0.00 8.44 1.17 4.34 2.65
ROIC — — — — — 0.00 7.70 7.68 12.31 9.80
ROE — — — — — 0.00 0.00 5.10 16.20 8.47
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Ardent Health, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SGRY Surgery Partners, Inc. $1.9B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
ASTH Astrana Health, Inc. $1.9B 44.3× 29.7× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44%
SNDA Sonida Senior Living, Inc. $1.7B — (loss-making) — (loss-making) +122.02% (above 0%: growing) n/m −291.70% (below 0%: shrinking) 34.97% (2.63%) Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.6B — (loss-making) — — n/m −4.18% (below 0%: shrinking) — 0.00% Compare
AMN AMN Healthcare Services Inc $1.6B 15.0× 31.2× +2.29% (above 0%: growing) n/m −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
AGL Agilon Health, Inc. $1.5B — (loss-making) — (loss-making) +7.15% (above 0%: growing) n/m −50.19% (below 0%: shrinking) 7.17% 0.79% Compare
PNTG The Pennant Group, Inc. $1.5B 44.5× 26.9× +35.76% (above 0%: growing) +23.81% (above 0%: growing) −50.94% (below 0%: shrinking) 14.07% 5.77% Compare
HCSG Healthcare Services Group, Inc. $1.5B 12.2× 19.2× +2.69% (above 0%: growing) n/m −26.02% (below 0%: shrinking) 15.89% 4.72% Compare
Median of peers $1.6B 29.7× 28.3× +7.15% — −55.78% 15.89% 3.77%

All 55 Medical Care Facilities stocks →

Ardent Health, Inc. (ARDT) key facts

  • Strength: Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024.
  • Ardent Health, Inc. (ARDT) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, ARDT traded at $11.95, a market capitalization of $1.7 billion.
  • Return on equity was 8.47% and debt-to-equity 0.63.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 1.97 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Ardent Health, Inc. (ARDT) Latest News

stockrow.com/ARDT · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com